In this edition of The 411 on 420, Perkins Coie partner Megan Morrissey was joined by Nancy Whiteman (CEO of Wana Brands), Gail Rand (CEO and Founder of grand consulting), and Allison Pugina (Category Manager of Canopy Growth Corporation) to discuss product development and branding strategies within the cannabis industry.  As co-authors of the recently-released white paper series entitled “Building New Foundations in the Cannabis Industry: Creating Gender Parity through Ownership, Leadership, Boards, Pay Equality, Branding, and Capital”, the group specifically discusses how cannabis companies can thoughtfully market to the female consumer base and increase overall revenue.

Listen to “Actionable Insights for Winning Product Development and Branding Strategies – Episode 14” on Spreaker.

Note that all episodes are available on AppleGoogle and Spotify.

Millions of Americans are utilizing medical cannabis and psilocybin to treat specific medical conditions each day. However, scientific and medical research lags in the U.S. lags behind other nations. Dr. Stephen M. Dahmer, Chief Medical Officer at Vireo Health, and Betty Aldworth, Director of Communications and Events at the Multidisciplinary Association for Psychedelic Studies (MAPS) join Perkins Coie senior counsel Andrew Kline to discuss the current dilemma and a path forward. During the podcast, the group discusses the current state of cannabis and psilocybin research, the barriers faced by researchers, and why it is critically important to have people who understand the science involved in policymaking.

Listen to “The Future of Cannabis and Psilocybin as Plant-Based Medicine: A Conversation with Stephen Dahmer and Betty Aldworth – Episode 13” on Spreaker.

Note that all episodes are available on AppleGoogle and Spotify.

 

While most people are discussing federal legalization of cannabis these days, the industry operates at a local level and the role of state-level cannabis associations is crucial. Perkins Coie associate Michael Bleicher is joined by Truman Bradley, Executive Director of the Marijuana Industry Group (MIG), the oldest and largest trade association in Colorado for the legal cannabis industry. During the podcast, Michael and Truman discuss how cannabis regulation currently varies all the way down to the city level and whether a one-size-fits-all approach to federal legalization would be effective or if a more nuanced approach is needed. Truman also shares his thoughts on how the pandemic has impacted the cannabis industry in Colorado. Continue Reading The Role of State-Level Cannabis Associations: A Conversation with Truman Bradley

Last week, Senators Schumer (D-NY), Booker (D-NJ), and Wyden (D-OR) circulated a discussion draft of the Cannabis Administration and Opportunity Act, a legislative proposal to deschedule and legalize cannabis.  In related statements to the Senate, Senator Schumer emphasized that cannabis legislation will be prioritized during this Congress, stating “it’s time to end the federal prohibition on marijuana [a]nd as majority leader, I am going to push this issue forward and make it a priority.”

While there is much to explore in the bill’s 163 pages, here are five immediate takeaways for the cannabis industry. Continue Reading Senators Propose Cannabis Descheduling Plan: Five Takeaways for The Cannabis Industry

The third version of the Marijuana Opportunity Reinvestment and Expungement, or MORE, Act was introduced on May 28. Perkins Coie lawyers Barak Cohen and Andrew Kline, in partnership with Yoko Miyashita, CEO of Leafly, authored an article discussing the bill. They make the case that Congress should regulate intentionally and make certain that state and federal regulatory authority is spelled out clearly in any cannabis descheduling bill. They also argue that a transition period is needed prior to interstate commerce or imports to ensure that we protect the public health, preserve critical social equity programs, and safeguard American jobs.

To read the article, click here.

As cannabis is legalized on a state-by-state basis, individual states are creating their own cannabis testing requirements to ensure consumer safety, and many of these requirements differ from one state to the next.  Perkins Coie associate Michael Bleicher is joined by Alena Rodriguez, Managing Director of Rm3 Labs, a leading cannabis testing laboratory in Colorado. During the podcast, Michael and Alena discuss the different testing guidelines for marijuana and hemp as well as new testing for delta-8 and delta-10. Alena also shares her thoughts on the role for state labs in a post descheduling world.

Listen to Cannabis Lab Testing and Standards Post De-Scheduling: A Conversation with Alena Rodriguez on Spreaker.

Note that all episodes are available on AppleGoogle and Spotify.

It is well known that the varying state regulations for cannabis give this industry a complex legal landscape.  Nowhere is that more apparent than in the state regulations related to cannabis packaging and labeling.  Perkins Coie senior counsel Andrew Kline is joined by Doug Fischer, General Counsel of Greenlane, the leading global platform for the development and distribution of premium cannabis accessories and lifestyle products. Throughout the podcast, Doug shares his thoughts on how descheduling could impact the cannabis industry. Doug and Andrew also touch on delta-8 and the medical community’s involvement in the industry.

Listen to Packaging and Labeling Post De-Scheduling: A Conversation with Doug Fischer on Spreaker.

Note that all episodes are available on AppleGoogle and Spotify.

Medical marijuana is playing an increasingly significant role in the quality of life for Americans, especially veterans. Perkins Coie partner Barak Cohen is joined by Nick Etten, Founder and Chairman of the Veterans Cannabis Project and Head of Government Affairs at Acreage Holdings. As veterans themselves, Barak and Nick discuss how veterans are utilizing cannabis as a way to cope with certain war-related injuries, such as post-traumatic stress and depression. Nick also shares his thoughts about current treatment options through the U.S. Department of Veterans Affairs (VA) and how the VA needs to evolve to effectively meet veterans’ healthcare needs

Listen to The Cannabis Industry for Veterans: A Conversation with Nick Etten on Spreaker.

Note that all episodes are available on AppleGoogle and Spotify.

In many real estate transactions, title insurance companies fulfill a variety of roles, from providing title reports and issuing title policies to acting as the escrow agent for the closing, any holdbacks, and construction draws. However, when it comes to transactions involving cannabis companies and/or properties that will be used for cannabis-related purposes, title companies are significantly limited in the services they offer. Continue Reading Cannabis, Real Estate & Title Companies

Today, the U.S. Federal Trade Commission (FTC) announced a settlement in its most recent law enforcement action in its ongoing efforts to monitor the marketplace regarding misleading cannabidiol (CBD) product claims. The action targets Kushly Industries LLC (Kushly) and the company’s sole officer for allegedly making false or unsupported health benefit claims about Kushly’s CBD product. Continue Reading FTC Continues Crackdown on Unsupported CBD Marketing